The U.S. Border Patrol is monitoring millions of American drivers nationwide in a secretive program to identify and detain people whose travel patterns it deems suspicious. (AP video: Marshall Ritzel) ...

Simple interest is paid only on the principal, e.g., a $10,000 investment at 5% yields $500 annually. Compound interest accumulates on both principal and past interest, increasing total returns over ...

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs to market in a press conference on Wednesday. The Food and Drug ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

The original version of this story appeared in Quanta Magazine. Imagine that someone gives you a list of five numbers: 1, 6, 21, 107, and—wait for it—47,176,870. Can you guess what comes next? If ...

The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie has reached a settlement with generic ...

ANDERLECHT, Belgium--(BUSINESS WIRE)--A.forall is pleased to announce the acquisition of four FDA-approved injectable generics and two late-stage pipeline assets from Provepharm's US portfolio. With ...

The Trump administration has excluded generic drugs from a baseline 15% tariff on imports from Japan under a new trade deal between the two countries. The “reciprocal” tariffs on Japanese products are ...

Medications are rarely made from start to finish in a single country; raw materials, active ingredients and final products often cross multiple borders before reaching patients in the U.S., The New ...

Tech leaders have been adamant that artificial intelligence will forever change industries, jobs, and skills. That remains to be seen in most industries, but in the world of software engineering, AI ...

A new analysis from GoodRx explores how 2025 is shaping up for Food and Drug Administration drug approvals, and the early data tells a mixed story. Importantly, a growing disconnect remains between ...